智通财经APP获悉,美股周一盘前,NovaBay(NBY.US)发布了2019Q2财报,该生物制药公司专注于将 Avenova 商业化用于国内眼部护理市场。 根据财报,期内,公司净销售额为180万美元;Avenova销售额为160万美元,环比增长9%。 该公司总裁兼首... 网页链接
格隆汇6月11日丨NovaBay(NBY)今日盘前涨39.03%,报6.31美元,昨日大涨874.84%。NovaBay是一家专注眼部护理市场的生物制药公司,专注于其非抗生素抗感染产品的商业化和开发,以满足全球局部抗感染市场尚未得到满足的治疗需求,其主推产品之一... 网页链接
5月10日Novabay制药(股票代码:NBY)公布财报,公告显示公司2018财年第一财季净利润为-215.00万美元,同比增长46.4%;营业收入为294.70万美元,同比下跌20.37%。 NovabayPharmaceutic ... 网页链接
$Novabay(NBY)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001437749-24-023740 Act: 34 Size: 1 MB 网页链接
$Novabay(NBY)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001437749-24-023641 Act: 33 Size: 538 KB 网页链接
$Novabay(NBY)$ POS EX Post-effective amendment adding exhibits to registration statement [Rule 462(d)] Accession Number: 0001437749-24-023629 Act: 33 Size: 64 KB 网页链接
$Novabay(NBY)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002275 Act: 33 Size: 1 KB 网页链接
$Novabay(NBY)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001437749-24-023391 Act: 33 Size: 1 MB 网页链接
$Novabay(NBY)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001437749-24-022700 Act: 33 Size: 776 KB 网页链接
$Novabay(NBY)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001437749-24-022528 Act: 34 Size: 24 KB 网页链接
$Novabay(NBY)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001437749-24-022526 Act: 34 Size: 193 KB 网页链接
$Novabay(NBY)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001437749-24-022466 Act: 34 Size: 3 MB 网页链接
$Novabay(NBY)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001437749-24-022434 Act: 33 Size: 1 MB 网页链接